Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.
Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC.
Botton T, et al. Among authors: allegra m.
Pigment Cell Melanoma Res. 2013 Nov;26(6):845-51. doi: 10.1111/pcmr.12148. Epub 2013 Aug 19.
Pigment Cell Melanoma Res. 2013.
PMID: 23890088
Free PMC article.